Filing Flows › ClearPoint Neuro (CLPT) › Q2 2026 › vs Q2 2025
ClearPoint Neuro (CLPT) Q2 2026 vs Q2 2025 (year over year)
ClearPoint Neuro's revenue rose $1.7M (+18%) from $9.2M in Q2 2025 to $10.9M in Q2 2026. The biggest changes: Product +$1.4M (+23%); Service +$286K (+9%).
ClearPoint Neuro, Q2 2026: revenue $10.9M (+18% year over year), operating margin -94.2%, net loss $11.3M, operating cash flow −$7.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Neurosurgery Navigation and Therapy Disposable Products | $5.6M | $3.4M | $2.1M | +62% |
| Biologics and Drug Delivery Services and License Fees | $3.1M | $2.9M | $220K | +8% |
| Biologics and Drug Delivery Disposable Products | $943K | $1.9M | −$928K | -50% |
| Capital Equipment and Software Systems and Software Products | $881K | $694K | $187K | +27% |
| Capital Equipment and Software Services | $416K | $350K | $66K | +19% |
| Product | $7.4M | $6.0M | $1.4M | +23% |
| Service | $3.5M | $3.2M | $286K | +9% |
| Revenue | $10.9M | $9.2M | $1.7M | +18% |
| Income tax benefit | $38K | −$25K | $63K | — |
| Net loss | $11.3M | $5.8M | $5.5M | +94% |
| Costs & expenses | $22.3M | $15.1M | $7.2M | +48% |
| Operating costs | $21.1M | $14.9M | $6.2M | +42% |
| Interest & other, net | $1.1M | $132K | $999K | +757% |
| Cost of revenue | $4.2M | $3.7M | $511K | +14% |
| Research & development | $4.6M | $3.8M | $803K | +21% |
| SG&A | $5.6M | $3.4M | $2.2M | +64% |
| Other operating costs | $6.8M | $4.0M | $2.7M | +68% |
| Operating cash sources | $11.3M | $5.8M | $5.5M | +94% |
| Depreciation & amortization | $150K | $396K | −$246K | -62% |
| Share-based compensation | $2.3M | $2.3M | $2K | +0.1% |
| Working capital & other | $1.9M | $620K | $1.3M | +207% |
| Cash used in operations | $7.0M | $2.6M | $4.5M | +175% |
| Net loss absorbed | $11.3M | $5.8M | $5.5M | +94% |
Questions
How much did ClearPoint Neuro's revenue grow year over year in Q2 2026?
ClearPoint Neuro's revenue rose $1.7M (+18%) from $9.2M in Q2 2025 to $10.9M in Q2 2026.
What drove ClearPoint Neuro's revenue change in Q2 2026?
Product +$1.4M (+23%); Service +$286K (+9%).